- Written by: (Investorideas.com newswire, breaking stock market
- Fri, 16 Aug 2024
- United States
August 16, 2024 (Investorideas.com Newswire) The biopharmaceutical industry remained resilient in the second quarter (Q2) of 2024 as global markets and investor optimism improved with anticipation of a potential interest rate cut from the US Federal Reserve.